Cosmetic Surgery Market By Procedure Type (Surgical Procedures {Breast Augmentation, Liposuction, Rhinoplasty, Abdominoplasty, Facelift, Buttock Augmentation, Hair Transplant, and Others} and Non-Surgical Procedures {Botox Injections, Dermal Fillers, Laser Hair Removal, Chemical Peels, Others}), By Age Group (18–30 Years, 30–50 Years, and 50 Years and Above), By Gender (Male and Female), By Technology (Laser-Assisted Technology, Radiofrequency, Ultrasound, Injectables, and Cryolipolysis), and By End-user (Hospitals, Cosmetic Surgery Centers, Ambulatory Surgical Centers, and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Cosmetic Surgery market accounted for USD 63.5 Billion in 2024 and is expected to reach USD 175.8 Billion by 2035, growing at a CAGR of around 9.7% between 2025 and 2035. The cosmetic surgery market refers to the surgical and non-surgical operations that modify the look of an individual. Such operations can be a facelift, liposuction, rhinoplasty, and implants in the chest area. It serves people who want surgery for cosmetic or post-accident purposes or who want to alter their appearance. Some of the reasons that they put forward include higher awareness of beauty, improved technology, surgical procedures, and the effect of social sites. The market is also growing because non-surgical procedures such as Botox and dermal fillers are getting popular.

Report Scope:

Market Dynamics

Medical tourism growth attracts international patients seeking affordable options.

Cosmetic Surgery Market is steadily developing due to various factors that shape the demand for foreign patients. The major reason is increasing awareness and desire for beauty and image-boosting as influenced by societal norms to look good, such as through social media influences. The rising availability of superior, intricate surgery and outpatient procedures makes cosmetic surgery attractive. The last thing to consider is the cost. Many patients go to other countries where the prices are lower than in their countries.

For instance, the American Society of Plastic Surgeons indicated that 1.8 million cosmetic surgeries were done in 2020, showcasing the strong market demand. Besides, access to accredited healthcare facilities is related to the development of medical tourism and affects patients from countries with high medical costs.

Potential risks and complications associated with surgical interventions.

Cosmetic Surgery Market is growing, although it is growing slowly due to several constraints. Firstly, the high cost of the treatments suggests it's an expensive service that can't help the general public by providing affordable operations. Elective procedures are not covered by insurance, and many people are unable to afford the procedure. They also pointed out regulatory issues and differences in market standards that slow down market development and negate patient safety and satisfaction. Furthermore, potential clients are hesitant to use the service due to the social stigma associated with surgery, particularly in societies with strict social norms. The operating prohibitive risk of developing complications after surgery and postoperative infections and discontentment with the results discourage people.

Greater attention to the psychological state of the patient leads to essential questions about the psychological attitudes towards such operations and to the revision of the criteria for admitting patients to operations. These factors create major difficulties for increasing the cosmetic surgery market’s development.

Integrating advanced technologies like AI for improved patient outcomes.

The application of advanced technologies such as artificial intelligence (AI) brings larger opportunities for the Cosmetic Surgery Market. AI benefits patients because it gives detailed recommendations to counteract anatomic differences and meet the patient’s expectations. Furthermore, patients have more confidence in the expected results of their therapies due to artificial intelligence's overnight use of imaging and simulations in patient care. Improvement of potential medical procedures is achieved using data on creatures of operations, and specific medical procedures following the surgery may lower the risk of surgical impossibilities and speed relief.

The application of AI helps to minimize classic paperwork, such as scheduling or billing, increasing the productivity of cosmetic practices. Consumers’ interest in aesthetic surgery increases, and using AI technologies increases clinics’ competitiveness and attracts the audience interested in the IT sector. The integration of AI into cosmetic surgery benefits clinical areas and helps to improve patient care in this fragmented industry.

Industry Experts Opinion

“Aesthetic Partners is one of the earliest players in the clinical aesthetics space and has demonstrated an exceptional track record of helping medical aesthetic, dermatology and plastic surgery practices across the country grow their businesses,"

• Sonya Brown, General Partner, Co-Head of Growth Equity at Norwest Venture Partners.

“A unique feature of cosmetic procedures is that it captures an array of health practitioners including GPs, dermatologists, ear nose and throat specialists, anesthetists, cosmetic surgeons, allied health and nurses,"

• Dr. Margaret Faux, Founder and Chief Executive Officer (CEO) of Synapse Medical Services.

Segment Analysis

Based on the procedure type, the Cosmetic Surgery Market is classified into Surgical Procedures and Non-Surgical Procedures. In the Cosmetic Surgery Market, non-surgical procedures grow due to their minimal level of invasiveness, shorter healing times, and lower costs. These procedures, like Botox, dermal fillers, and laser treatments, are more popular than surgical procedures because they are invasive and have fewer complications than surgical procedures. Non-surgical procedures now account for the major portion of the market because of the growing trend of "look" improvement without the need for surgery. Similarly, technological advancements have increased the safety and therapeutic efficacy of numerous interventions, leading to their use.

Based on the technology, the Cosmetic Surgery Market is classified into Laser-Assisted Technology, Radiofrequency, Ultrasound, Injectables, and Cryolipolysis. Injectables are the most significant and dominant sector in the cosmetic surgery market, according to a comparative analysis of the market share distribution. Among these are dermal fillers and Botox, which have gained fame because they lack surgery, patients can stay in the hospital for a limited period, and they are less expensive than surgery. Injectables are in demand because of their ability to smooth out wrinkles and give the face structure, and they are quick and efficient. Furthermore, the increase in minimally invasive cosmetic surgery has seen injectables as a demanded form of cosmetic enhancement among patients who desire to undergo surgery.

Regional Analysis

The Asian-Pacific Cosmetic Surgery Market is witnessing significant growth due to rising income, the development of the middle class, and cosmetic enhancements. Some of the key players in this industry include countries such as South Korea, Japan, and Thailand. The region's technological enhancements and doctors' proficiency in performing cosmetic surgeries attract overseas patients, leading to market growth. The culture of beauty perception has been changing, and people are inclined toward the surgery for aesthetic reasons. The region's appeal for cosmetic surgery is increased by the strengthening of rules and regulations for patient safety and care.

The European Cosmetic Surgery Market is growing due to the rich cultural heritage of the region and divergent beauty standards. Leading countries like Germany, Italy, and France are executing a good balance between interventions and invasive and non-invasive procedures. Minimally invasive options with botulinum toxin and dermal fillers have grown immensely popular due to their convenience and shorter recovery times. The market is fueled by growing awareness about cosmetic procedures along with technology development and technique enhancement. Furthermore, increased regulation and an understanding of the need for greater patient safety are shaping the sector.

Competitive Landscape 

Cosmetic Surgery Market is highly saturated due to the constant development of innovations and the growing demand for aesthetic procedures. Prominent players include Allergan, famous for its revolutionary Botox and dermal fillers, and Ipsen S.A., which supplies Dysport. Revance Therapeutic Inc. has advanced in the profitability of its Daxibotulinum toxin A injectable, showcasing a longer duration of effectiveness than conventional botulinum toxins. Furthermore, Medytox has recently continued to penetrate the international market with its superior botulinum toxins. Firms like Sientra, Inc., and Croma-Pharma GmbH enter the market with new aesthetic solutions to fulfill customers’ requirements, increasing the competition among those firms.

Cosmetic Surgery Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In May 2024, Olympus Cosmetic Group, backed by VSS Capital Partners, completed the acquisition of Artisan, a prominent cosmetic surgery and medspa company based in Atlanta. This acquisition expands Olympus’ presence in the Southeastern U.S., bringing together two leaders in cosmetic surgery and medspa services to enhance patient care.
• In January 2023, Apyx Medical Corporation introduced its latest Renuvion technology, the Apyx One Console, designed for cosmetic surgical procedures in the U.S. This multifunctional device integrates a 3-in-1 energy system, allowing surgeons to perform procedures using helium plasma, along with monopolar and bipolar energy.

Report Coverage:

By Procedure Type

• Surgical Procedures
  • Breast Augmentation
  • Liposuction
  • Rhinoplasty
  • Abdominoplasty
  • Facelift
  • Buttock Augmentation
  • Hair Transplant
  • Others
• Non-Surgical Procedures
  • Botox Injections
  • Dermal Fillers
  • Laser Hair Removal
  • Chemical Peels
  • Others

By Age Group

• 18–30 Years
• 30–50 Years
• 50 Years and Above

By Gender

• Male
• Female

By Technology

• Laser-Assisted Technology
• Radiofrequency
• Ultrasound
• Injectables
• Cryolipolysis

By End-user

• Hospitals
• Cosmetic Surgery Centers
• Ambulatory Surgical Centers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Allergan
• Ipsen S.A.
• Medytox
• Revance Therapeutics, Inc.
• Galderma S.A.
• Sientra, Inc.
• Hugel, Inc.
• Croma-Pharma GmbH
• Cutera, Inc.
• Aesthetics Biomedical, Inc.
• Bausch Health Companies Inc.
• Alcon, Inc.
• Medytox, Inc.
• Hugel, Inc.
• Revance Therapeutics, Inc.

Frequently Asked Questions (FAQs)